The global X-linked hypophosphatemia (XLH) Market size was valued at USD 2,386.3 million in 2023 and is expected to grow at an 10.8% CAGR from 2024 to 2030. It also includes market size and projection estimations for each of the five major regions from 2024 to 2030. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the...